Tema para la discusión del lunes:
¿hay que medir #péptidosnatriuréticos ( #PN ) a todas las #personas con #diabetESP ?🩸

¿Es algo que hacemos por rutina en consulta o no?🧐

Este paper de 2022 plantea la monitorización al menos de forma anual en #DM2 :
🔗doi.org/10.1016/j.rec.…

#Neumología | ➡Los pacientes con #EPOC tienen más posibilidades de presentar patología #cardiovascular .
➡De hecho, un #40% fallecerá por esta causa, según estudios de Nicolas Manito y Salud Santos, ambos del Hospital Universitari Bellvitge | HUB

✍ RAQUEL SERRANO
dozz.es/7otiq1

Grateful to share at #ISHLT24 the results of the study guided by Dr. Gabriel Moreno Gabriel Moreno-Gonzalez 📑 Thanks to all the collaborating transplant teams! Alba Maestro Benedicto Teresa Blasco Marta Farrero Nicolas Manito Raquel López Vilella Eduardo Zatarain

Excited to share Lorena's poster presentation at #ISHLT24 Congress on the role of DBD donors’ biomarkers in PGD and post-HTx rejection🫀Lorena Herrador Coordinació de Trasplantaments de Bellvitge Gabriel Moreno-Gonzalez

Incredible day for the UTC Hospital Universitari Bellvitge | HUB at #ISHLTcongress ! Carles Díez advocates for pre-LVAD pre-optimization, followed by the Late Breaking Trial ELISPOT-TC results. 📊 Meanwhile, Dr. González-Costello moderates a fascinating session on bridging bench to bedside LVAD research.

Comentarios a la actualización 2023 de la guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica #REC Domingo Pascual-Figal Nicolas Manito Marta Cobo Marcos Inés Gómez Otero Julio Alejandro Recio revespcardiol.org//es-comentario…

RELIEVE-HF trial #ACC24 Interatrial shunt device in patients with #heartfailure across the full range of LVEF

➖ Neutral trial, no benefit on CV events, safe procedure

➖LVEF analysis suggests 🟢 benefit in patients with HFrEF and🔴 harm in patients with LVEF>40%

EMPACT-MI NEJM #ACC24

Empagliflozin vs placebo among patients at increased risk for #heartfailure after acute myocardial infarction

➖ Empa did not lead to a significantly lower risk of a first 🏥 for #heartfailure or death from any cause than placebo.

➖ 23% ⤵️ risk of 🏥…

⚠️ Insights from the EMPACT-MI Trial‼️

📍 In patients after AMI with left ventricular dysfunction or congestion, empagliflozin reduced the risk of HF

#ACC24 Soc Esp Cardiología Julio Marta Cobo Marcos Rafael de la Espriella Enrique Santas

ahajournals.org/doi/10.1161/CI…

Dapagliflozin and Timing of Prior HF🏥
Meta-Analysis of #DAPA -HF & #DELIVER

👥11007 ➡️12.4% were 🏥 for HF within 3 months of randomization, 14.2% between 3 and 12 months, and 16.8% > 1 year before randomization
👉 risk of the primary endpoint was inversely associated with time

Learn more about our kidney #xenotransplant Mass General Transplant
This short video provides an overview of the rationale, the details about the immunosuppression used, and the precautions taken in our study. Click on the second video in the video section @ leoriella.com

With tremendous joy, I share that our patient who received a gene-edited pig kidney transplant was discharged home today after removal of his dialysis access. We hope that this is a first step that will bring hope to many patients waiting for a kidney transplant #xenotransplant

👉 Arrenca la II Jornada d'Actualització en Donació en Asistòlia Controlada i Complexa, amb el Dr. Gabriel Moreno-Gonzalez Director de Programa de Donació de l'' #hbellvitge , el Dr. Nicolas Manito, conductor de la jornada i el Dr. Arcocha, Director Mèdic👌
#orgullbellvitge

✅The Cardioprotective and Anticancer Effects of SGLT2i

👉 Observational studies suggest SGLT2I protect from cardiotoxic chemotherapy.

👉Preclinical studies show cardioprotective and anticancer effects of SGLT2i.

👉Randomized clinical trials are warranted to test SGLT2I in…

✅Dapagliflozin in HF👥 & previous myocardial infarction: pooled analysis of DAPA-HF + DELIVER

📁11 007➡️3731 (34%) had a previous MI

💊Dapagliflozin:
👉⬇️ the risk of the primary outcome to a similar extent in patients with (HR 0.83) and without previous MI (HR 0.76;…

🤩🤩🤩 Muy orgulloso del curso que habéis montado y de trabajar cada día con vosotros. Felicitats!! Carles Díez Elena García Romero Lorena Herrador Laura Triguero

Amazing meeting, so pleased to be part of it. Congratulations on a fantastic program and speakers. A must for Advanced Heart Failure lovers! #XCursoAsistenciaCirculatoriaMecánica Hospital Universitari Bellvitge | HUB

⚠️Practical Requirements for the Development of an Advanced #Cardiorenal Unit

👉real challenge
👉multilevel action plan:
📌covering governance & management, 📌type of patient
📌personnel requirements
📌service portfolio
📌care process
📌information systems
👉Specific lines of…

SGLT2i are associated with anti-atrophic, anti-inflammatory, and pro-metabolic effects in skeletal muscle in patients with #heartfailure

☑️ Less muscle atrophy by 20%, as directly assessed in biopsies European Society of Cardiology Journals #CardioTwitter

onlinelibrary.wiley.com/doi/full/10.10…

👍 Hoy he asistido al comité de trasplantes para valorar resultados del 2023 Hospital Universitari Bellvitge | HUB : Liderazgo, organización, proyectos y calidad asistencial. Grandes profesionales que están orientados a configurar el futuro del trasplante y la donación de órganos/tejidos #OrgullBellvitge